PortfoliosLab logo

Akero Therapeutics, Inc. (AKRO)

Equity · Currency in USD · Last updated Apr 1, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in Akero Therapeutics, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $20,884 for a total return of roughly 108.84%. All prices are adjusted for splits and dividends.


50.00%100.00%150.00%200.00%NovemberDecember2023FebruaryMarch
108.84%
39.10%
AKRO (Akero Therapeutics, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with AKRO

Akero Therapeutics, Inc.

Return

Akero Therapeutics, Inc. had a return of -30.18% year-to-date (YTD) and 162.05% in the last 12 months. Over the past 10 years, Akero Therapeutics, Inc. had an annualized return of 21.52%, outperforming the S&P 500 benchmark which had an annualized return of 9.13%.


PeriodReturnBenchmark
1 month-15.93%3.51%
Year-To-Date-30.18%7.03%
6 months28.39%12.88%
1 year162.05%-10.71%
5 years (annualized)21.52%9.13%
10 years (annualized)21.52%9.13%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023-9.67%-8.06%
2022189.79%24.11%10.03%17.85%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Akero Therapeutics, Inc. Sharpe ratio is 1.04. A Sharpe ratio greater than 1.0 is considered acceptable.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00NovemberDecember2023FebruaryMarch
1.04
-0.46
AKRO (Akero Therapeutics, Inc.)
Benchmark (^GSPC)

Dividend History


Akero Therapeutics, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2023FebruaryMarch
-30.18%
-14.33%
AKRO (Akero Therapeutics, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Akero Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Akero Therapeutics, Inc. is 79.96%, recorded on Jun 1, 2022. It took 93 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-79.96%Jul 10, 2020478Jun 1, 202293Oct 13, 2022571
-57.16%Aug 29, 2019139Mar 18, 202073Jul 1, 2020212
-31.99%Jan 3, 202354Mar 21, 2023
-17.41%Dec 19, 20221Dec 19, 20223Dec 22, 20224
-14.83%Jun 27, 20199Jul 10, 20192Jul 12, 201911
-13.27%Oct 25, 202210Nov 7, 20226Nov 15, 202216
-10.67%Dec 1, 20224Dec 6, 20228Dec 16, 202212
-9.04%Jul 29, 20192Jul 30, 20196Aug 7, 20198
-8.22%Jun 24, 20192Jun 25, 20191Jun 26, 20193
-7.35%Aug 8, 20192Aug 9, 20198Aug 21, 201910

Volatility Chart

Current Akero Therapeutics, Inc. volatility is 70.51%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%140.00%NovemberDecember2023FebruaryMarch
70.51%
15.42%
AKRO (Akero Therapeutics, Inc.)
Benchmark (^GSPC)